(VIANEWS) – Today, the Innrs artificial intelligence algorithm suggests a high probability of discovering the approximate price for tomorrow of Celsius Holdings CELH, Canaan CAN and others.
Via News will regularly fact-check this AI algorithm that aims to consistently predict the next session price and next week’s trend of financial assets.
Innrs provides A.I.-based statistical tools to help investors make decisions. The table below shows the financial assets predicting price, ordered by the highest expected accuracy.
Innrs officials say this tool helps investors make better-informed decisions, supposedly used alongside other relevant financial information and the specific trader strategy.
In the next session, Via News will report the finding on the algorithm precision.
|Financial Asset||Accuracy||Close Price||Prediction|
|Celsius Holdings (CELH)||92.91%||$203.22||⇧ $210.93|
|Canaan (CAN)||90.76%||$1.88||⇩ $1.81|
|GoPro (GPRO)||88.95%||$3.43||⇩ $3.35|
|T-Mobile (TMUS)||88.93%||$138.24||⇧ $141.21|
|Catalent (CTLT)||88.88%||$48.44||⇧ $48.77|
|CarMax (KMX)||88.77%||$81.8||⇧ $83.6|
|Petroleo Brasileiro (PBR)||88.65%||$14.8||⇩ $14.74|
|Electronic Arts (EA)||88.48%||$121.71||⇧ $124.88|
|Alnylam Pharmaceuticals (ALNY)||88.32%||$205.31||⇧ $208.65|
|American Express (AXP)||87.73%||$157.44||⇧ $164.34|
1. Celsius Holdings (CELH)
Shares of Celsius Holdings jumped by a staggering 17.5% in from $172.95 to $203.22 at 19:21 EST on Friday, after three consecutive sessions in a row of gains. NASDAQ is jumping 0.09% to $13,761.53, after four sequential sessions in a row of losses.
Celsius Holdings, Inc. develops, processes, markets, distributes, and sells functional drinks and liquid supplements in the United States and internationally. The company offers various carbonated and non-carbonated functional energy drinks under the CELSIUS Originals name; dietary supplement in carbonated flavors, including apple jack'd, orangesicle, inferno punch, cherry lime, blueberry pomegranate, strawberry dragon fruit, tangerine grapefruit, and jackfruit under the CELSIUS HEAT name; and branched-chain amino acids functional energy drink that fuels muscle recovery under the CELSIUS BCCA+ENERGY name. It also provides CELSIUS On-the-Go, a powdered form of the active ingredients in functional energy drinks in individual On-The-Go packets and canisters; and sparkling grapefruit, cucumber lime, and orange pomegranate, as well as pineapple coconut, watermelon berry, and strawberries and cream non-carbonated functional energy drinks under the CELSIUS Sweetened name; and CELSIUS ready-to drink products. It distributes its products through direct-to-store delivery distributors and direct to retailers, include supermarkets, convenience stores, drug stores, nutritional stores, and mass merchants, as well as health clubs, spas, gyms, the military, and e-commerce websites. The company was formerly known as Vector Ventures, Inc. and changed its name to Celsius Holdings, Inc. in January 2007. Celsius Holdings, Inc. was founded in 2004 and is headquartered in Boca Raton, Florida.
Celsius Holdings’s last week, last month’s, and last quarter’s current intraday variation average was 1.57%, 1.77%, and 2.04%.
Celsius Holdings’s highest amplitude of average volatility was 1.57% (last week), 2.81% (last month), and 2.04% (last quarter).
More news about Celsius Holdings.
2. Canaan (CAN)
Shares of Canaan fell by a staggering 47.87% in from $3.61 to $1.88 at 19:21 EST on Friday, following the last session’s upward trend. NASDAQ is jumping 0.09% to $13,761.53, after four consecutive sessions in a row of losses.
Canaan Inc. engages in the research, design, and sale of integrated circuit (IC) final mining equipment products by integrating IC products for bitcoin mining and related components in the People's Republic of China. It is also involved in the assembly and distribution of mining equipment and spare parts. The company has operations in the United States, Australia, Kazakhstan, Hong Kong, Canada, Mainland China, Thailand, Sweden, and internationally. Canaan Inc. was founded in 2013 and is based in Singapore.
Year-on-year quarterly revenue growth declined by 72.6%, now sitting on 490.93M for the twelve trailing months.
Canaan’s sales growth is negative 46.5% for the present quarter and 90.6% for the next.
Yearly Top and Bottom Value
Canaan’s stock is valued at $1.88 at 19:21 EST, way below its 52-week high of $3.98 and above its 52-week low of $1.83.
More news about Canaan.
3. GoPro (GPRO)
Shares of GoPro dropped by a staggering 14.29% in from $4 to $3.43 at 19:21 EST on Friday, after three successive sessions in a row of losses. NASDAQ is jumping 0.09% to $13,761.53, after four successive sessions in a row of losses.
GoPro, Inc. develops and sells cameras, mountable and wearable accessories, and subscription services and software in the Americas, Europe, the Middle East, Africa, the Asia and Pacific region, and internationally. The company provides cloud connected HERO11 Black, HERO11 Black Mini, HERO10 Black, HERO10 Black Bones, HERO9 Black, and HERO8 Black waterproof cameras; MAX, a 360-degree waterproof camera; GoPro, a subscription service that includes full access to the Quik app, cloud storage supporting source video and photo quality, camera replacement, and damage protection; Quik subscription offers access to editing tools, which allows users to edit photos, videos, and create cinematic stories; and Quik app, a mobile app that enable users to get their favorite photos and videos with footage from any phone or camera. It also offers mounts and accessories comprising equipment-based mounts consisting of helmet, handlebar, roll bar, and tripod mounts that enable consumers to wear the mount on their bodies, such as wrist housings, magnetic swivel clips, chest harnesses, and head straps; media, display, and light mods; spare batteries, dive filters, and charging accessories and cables; and lifestyle gears. In addition, the company provides mobile and web applications that provides media workflow for archiving, editing, multi-clip story creation, and sharing content on the fly. GoPro, Inc. markets and sells its products through retailers and wholesale distributors, as well as through its GoPro.com website. The company was formerly known as Woodman Labs, Inc. and changed its name to GoPro, Inc. in February 2014. GoPro, Inc. was founded in 2002 and is headquartered in San Mateo, California.
Previous days news about GoPro
- Gopro (gpro) rolls out new hero12 black camera: key takeaways. According to Zacks on Thursday, 7 September, "The company is also launching a new Quik desktop app which is available to GoPro subscribers at no extra cost. ", "Headquartered in San Mateo, CA, GoPro is one of the leading manufacturers of the world’s most handy camera and enabler of some of today’s most immersive and engaging content. "
More news about GoPro.
4. T-Mobile (TMUS)
Shares of T-Mobile jumped 0.47% in from $137.59 to $138.24 at 19:21 EST on Friday, following the last session’s upward trend. NASDAQ is jumping 0.09% to $13,761.53, after four consecutive sessions in a row of losses.
T-Mobile US, Inc., together with its subsidiaries, provides mobile communications services in the United States, Puerto Rico, and the United States Virgin Islands. The company offers voice, messaging, and data services to customers in the postpaid, prepaid, and wholesale and other services. It also provides wireless devices, including smartphones, wearables, tablets, home broadband routers, and other mobile communication devices, as well as wireless devices and accessories; financing through equipment installment plans; leasing through JUMP! On Demand; and High Speed Internet services. In addition, the company offers services, devices, and accessories under the T-Mobile and Metro by T-Mobile brands through its owned and operated retail stores, T-Mobile app and customer care channels, and its websites. It also sells its devices to dealers and other third-party distributors for resale through independent third-party retail outlets and various third-party websites. The company was founded in 1994 and is headquartered in Bellevue, Washington.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, T-Mobile’s stock is considered to be overbought (>=80).
Previous days news about T-Mobile
- : t-mobile US sets $19 billion shareholder return program, including first-ever dividend payment. According to MarketWatch on Wednesday, 6 September, "Shares of T-Mobile US Inc. took a hit Wednesday, even after the Washington-based wireless-communications company said it approved a $19 billion shareholder-return program to run through 2024 that includes both stock buybacks and dividends."
More news about T-Mobile.
5. Catalent (CTLT)
Shares of Catalent jumped 4.74% in from $46.25 to $48.44 at 19:21 EST on Friday, after three consecutive sessions in a row of losses. NYSE is rising 0.09% to $15,878.99, after three successive sessions in a row of losses.
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products, such as prescription drugs, over-the-counter medications, dietary supplements, unit-dose cosmetics, and animal health medicinal preparations. The Biologics segment provides biologic cell-line; develops and manufactures cell therapy and viral based gene therapy; formulation, development, and manufacturing for parenteral dose forms, including vials, prefilled syringes, vials, and cartridges; and analytical development and testing services. The Oral and Specialty Delivery segment offers formulation, development, and manufacturing across a range of technologies along with integrated downstream clinical development and commercial supply solutions. This segment also offers oral delivery solutions platform comprising pre-clinical screening, formulation, analytical development, and current good manufacturing practices services. The Clinical Supply Services segment offers manufacturing, packaging, storage, distribution, and inventory management for drugs and biologics, and cell and gene therapies in clinical trials. The company also offers FlexDirect direct-to-patient and FastChain demand-led clinical supply services. It serves pharmaceutical, biotechnology, and consumer health companies; and companies in other healthcare market segments, such as animal health and medical devices, as well as in cosmetics industries. The company was incorporated in 2007 and is headquartered in Somerset, New Jersey.
Catalent’s sales growth for the current quarter is negative 8%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Catalent’s stock is considered to be overbought (>=80).
Year-on-year quarterly revenue growth declined by 18.5%, now sitting on 4.5B for the twelve trailing months.
More news about Catalent.
6. CarMax (KMX)
Shares of CarMax fell 1.64% in from $83.16 to $81.80 at 19:21 EST on Friday, following the last session’s upward trend. NYSE is jumping 0.09% to $15,878.99, after three sequential sessions in a row of losses.
CarMax, Inc., together with its subsidiaries, operates as a retailer of used vehicles in the United States. It operates in two segments, CarMax Sales Operations and CarMax Auto Finance. The company offers customers a range of makes and models of used vehicles, including domestic, imported, and luxury vehicles, as well as hybrid and electric vehicles; and extended protection plans to customers at the time of sale, as well as sells vehicles that are approximately 10 years old and has more than 100,000 miles through wholesale auctions. It also provides reconditioning and vehicle repair services; and financing alternatives for retail customers across a range of credit spectrum through its CarMax Auto Finance and arrangements with various financial institutions. The company was founded in 1993 and is based in Richmond, Virginia.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter is a negative 3.8% and positive 104.2% for the next.
More news about CarMax.
7. Petroleo Brasileiro (PBR)
Shares of Petroleo Brasileiro jumped 7.79% in from $13.73 to $14.80 at 19:21 EST on Friday, following the last session’s downward trend. NYSE is jumping 0.09% to $15,878.99, after three successive sessions in a row of losses.
Petróleo Brasileiro S.A. – Petrobras explores, produces, and sells oil and gas in Brazil and internationally. The company operates through Exploration and Production; Refining, Transportation and Marketing; and Gas and Power. It also engages in prospecting, drilling, refining, processing, trading, and transporting crude oil from producing onshore and offshore oil fields, and shale or other rocks, as well as oil products, natural gas, and other liquid hydrocarbons. The Exploration and Production segment explores, develops, and produces crude oil, natural gas liquids, and natural gas primarily for supplies to the domestic refineries. The Refining, Transportation and Marketing segment engages in the refining, logistics, transport, marketing, and trading of crude oil and oil products; exportation of ethanol; and extraction and processing of shale, as well as holding interests in petrochemical companies. The Gas and Power segment is involved in the logistic and trading of natural gas and electricity; transportation and trading of LNG; generation of electricity through thermoelectric power plants; holding interests in transportation and distribution of natural gas; and fertilizer production and natural gas processing business. In addition, the company produces biodiesel and its co-products, and ethanol; and distributes oil products. Further, it engages in research, development, production, transport, distribution, and trading of energy. Petróleo Brasileiro S.A. – Petrobras was incorporated in 1953 and is headquartered in Rio de Janeiro, Brazil.
Petroleo Brasileiro’s last week, last month’s, and last quarter’s current intraday variation average was 1.51%, 0.52%, and 1.82%.
Petroleo Brasileiro’s highest amplitude of average volatility was 1.51% (last week), 1.59% (last month), and 1.82% (last quarter).
More news about Petroleo Brasileiro.
8. Electronic Arts (EA)
Shares of Electronic Arts fell 0.39% in from $122.19 to $121.71 at 19:21 EST on Friday, following the last session’s upward trend. NASDAQ is jumping 0.09% to $13,761.53, after four sequential sessions in a row of losses.
Electronic Arts Inc. develops, markets, publishes, and distributes games, content, and services for game consoles, PCs, mobile phones, and tablets worldwide. It develops and publishes games and services across various genres, such as sports, racing, first-person shooter, action, role-playing, and simulation primarily under the Battlefield, The Sims, Apex Legends, Need for Speed, and license games from others, including FIFA, Madden NFL, UFC, and Star Wars brands. The company licenses its games to third parties to distribute and host its games. It markets and sells its games and services through digital distribution and retail channels, as well as directly to mass market retailers, specialty stores, and distribution arrangements. Electronic Arts Inc. was incorporated in 1982 and is headquartered in Redwood City, California.
More news about Electronic Arts.
9. Alnylam Pharmaceuticals (ALNY)
Shares of Alnylam Pharmaceuticals rose by a staggering 10.73% in from $185.41 to $205.31 at 19:21 EST on Friday, following the last session’s downward trend. NASDAQ is rising 0.09% to $13,761.53, after four consecutive sessions in a row of losses.
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system (CNS)/ocular diseases. Its marketed products include ONPATTRO (patisiran), a lipid complex injection for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; GIVLAARI for the treatment of adults with acute hepatic porphyria (AHP); and OXLUMO (lumasiran) for the treatment of primary hyperoxaluria type 1 (PH1). In addition, the company is developing givosiran for the treatment of adolescent patients with AHP; patisiran for the treatment of transthyretin amyloidosis, or ATTR amyloidosis, with cardiomyopathy; cemdisiran to treat complement-mediated diseases; ALN-AAT02 for the treatment of AAT deficiency-associated liver disease; ALN-HBV02 to treat chronic HBV infection; Zilebesiran to treat hypertension; and ALN-HSD to treat NASH. Further, it offers Fitusiran for the treatment of hemophilia and rare bleeding disorders, Inclisiran to treat hypercholesterolemia, lumasiran for the treatment of advanced PH1 and recurrent renal stones, and vutrisiran for the treatment of ATTR amyloidosis, which is in phase 3 clinical trial. Alnylam Pharmaceuticals, Inc. has strategic collaborations with Regeneron Pharmaceuticals, Inc. to discover, develop, and commercialize RNAi therapeutics for a range of diseases by addressing therapeutic targets expressed in the eye and CNS; and Sanofi Genzyme to discover, develop, and commercialize RNAi therapeutics. It also has license and collaboration agreements with Novartis AG; Vir Biotechnology, Inc.; Dicerna Pharmaceuticals, Inc.; Ionis Pharmaceuticals, Inc.; and PeptiDream, Inc. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.
Yearly Top and Bottom Value
Alnylam Pharmaceuticals’s stock is valued at $205.31 at 19:21 EST, way below its 52-week high of $242.97 and way above its 52-week low of $178.64.
Alnylam Pharmaceuticals’s sales growth is 36.7% for the present quarter and 21.3% for the next.
More news about Alnylam Pharmaceuticals.
10. American Express (AXP)
Shares of American Express fell 3.62% in from $163.35 to $157.44 at 19:21 EST on Friday, after two consecutive sessions in a row of losses. NYSE is jumping 0.09% to $15,878.99, after three sequential sessions in a row of losses.
American Express Company, together with its subsidiaries, provides charge and credit payment card products, and travel-related services worldwide. The company operates through three segments: Global Consumer Services Group, Global Commercial Services, and Global Merchant and Network Services. Its products and services include payment and financing products; network services; accounts payable expense management products and services; and travel and lifestyle services. The company's products and services also comprise merchant acquisition and processing, servicing and settlement, point-of-sale marketing, and information products and services for merchants; and fraud prevention services, as well as the design and operation of customer loyalty programs. It sells its products and services to consumers, small businesses, mid-sized companies, and large corporations through mobile and online applications, third-party vendors and business partners, direct mail, telephone, in-house sales teams, and direct response advertising. American Express Company was founded in 1850 and is headquartered in New York, New York.
American Express’s sales growth is 13.6% for the ongoing quarter and 13.1% for the next.
American Express’s value is under its 50-day moving average of $168.15 and below its 200-day moving average of $162.21.
More news about American Express.